Chlordiazepoxide — Membership Pricing

Other medications in Mental Health

• Chlorpromazine
• Citalopram
• Clomipramine
• Clonazepam
• Clonidine
• Clorazepate
• Clozapine
• Desipramine

About Chlordiazepoxide

Chlordiazepoxide is a prescription medication primarily used to treat anxiety and alcohol withdrawal symptoms. Understanding its purpose and how to manage its cost is crucial. At TheDrugClub, we're dedicated to helping our members navigate prescription expenses, offering opportunities for significant savings on medications like chlordiazepoxide to ensure care is more affordable.

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Chlordiazepoxide is approved for (FDA label)

Chlordiazepoxide HCl capsules are indicated for the management of anxiety disorders or for the short term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of chlordiazepoxide HCl capsules in long term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.

Source: Read the full FDA label on DailyMed. Label effective date: July 10, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Boxed warning for Chlordiazepoxide (FDA label)

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation (see WARNINGS and PRECAUTIONS ). The use of benzodiazepines, including chlordiazepoxide hydrochloride capsules, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes. Before prescribing chlordiazepoxide hydrochloride capsules and throughout treatment, assess each patient’s risk for abuse, misuse, and addiction (see WARNINGS ). The continued use of benzodiazepines, including chlordiazepoxide hydrochloride capsules, may lead to clinically significant physical dependence. The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Abrupt discontinuation or rapid dosage reduction of chlordiazepoxide hydrochloride capsules after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue chlordiazepoxide hydrochloride capsules or reduce the dosage (see DOSAGE AND ADMINISTRATION and WARNINGS ).

Source: FDA prescribing information (DailyMed). Set ID: 9aba3135-00ff-47ba-b926-55eb16b361bf. SPL document ID: 56443751-86df-0037-e063-6294a90ae2b4. Label effective date: July 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Chlordiazepoxide (FDA label)

The necessity of discontinuing therapy because of undesirable effects has been rare. Drowsiness, ataxia and confusion have been reported in some patients particularly the elderly and debilitated. While these effects can be avoided in almost all instances by proper dosage adjustment, they have occasionally been observed at the lower dosage ranges. In a few instances syncope has been reported. Other adverse reactions reported during therapy include isolated instances of skin eruptions, edema, minor menstrual irregularities, nausea and constipation, extrapyramidal symptoms, as well as increased and decreased libido. Such side effects have been infrequent, and are generally controlled with reduction of dosage. Changes in EEG patterns (low-voltage fast activity) have been observed in patients during and after chlordiazepoxide HCl treatment.

Source: FDA prescribing information (DailyMed). Set ID: 9aba3135-00ff-47ba-b926-55eb16b361bf. SPL document ID: 56443751-86df-0037-e063-6294a90ae2b4. Label effective date: July 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Chlordiazepoxide (FDA label)

Chlordiazepoxide HCl capsules are contraindicated in patients with known hypersensitivity to the drug.

Source: FDA prescribing information (DailyMed). Set ID: 9aba3135-00ff-47ba-b926-55eb16b361bf. SPL document ID: 56443751-86df-0037-e063-6294a90ae2b4. Label effective date: July 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.